Evolus (EOLS) Reports Prelim Q4 Revenue of $34.7M
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/31/2026
- Wall St set for lower open as Middle East clashes revive rate-hike speculation
- The Warsh pivot markets didn't expect
- Oil rises over 2% as US and Iran resume military attacks
- Energy stocks rally as fresh U.S.-Iran attacks drive oil prices higher
- BofA turns S&P 500 signals from red to yellow: What to buy now
- GameStop posts higher income despite revenue drop in Q2 2026
- At least eight die, 18 missing after ferry capsizes off North Cyprus
- Manhunt underway after woman killed, several injured at Swiss rave shooting
- Aon close to acquiring USI Insurance from KKR in $17 billion deal, WSJ reports
- RedHill sells Talicia to Apotex for $18M upfront plus milestones
Business Update Support Positive Thesis on Evolus (EOLS), Guidance Looks Conservative, Reiterate Overweight - Cantor Fitzgerald
January 26, 2022 2:30 PM ESTCantor Fitzgerald analyst Louise Chen reiterated an Overweight rating and $20.00 price target on Evolus (NASDAQ: EOLS), following the company's recent business update.
The analyst quotes: "Today (1/26), EOLS provided a business update that supports our positive investment thesis on the stock. The company: 1) exceeded revenue... More
